Trials / Conditions / Stage IIIC Non-Small Cell Lung Cancer
Stage IIIC Non-Small Cell Lung Cancer
4 registered clinical trials studyying Stage IIIC Non-Small Cell Lung Cancer — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Neoadjuvant SBRT Followed by Sintilimab Plus Chemotherapy for N3-Positive NSCLC NCT07309952 | Yang Hong | Phase 2 |
| Recruiting | Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to TKI in Patients With Advanced NS NCT06167460 | Gene Solutions | — |
| Completed | Study of ONO-7475 in Combination With Osimertinib in EGFR Gene Mutation-positive Non-small Cell Lung Cancer NCT06525246 | Ono Pharmaceutical Co., Ltd. | Phase 1 |
| Completed | Magnetic Resonance-Guided Hypofractionated Adaptive Radiation Therapy With Concurrent Chemotherapy and Consoli NCT03916419 | Washington University School of Medicine | Phase 2 |